Granddaughters of women exposed to DDT have 2-3 times higher chance of obesity, early periods, study says
A recent study found that granddaughters of women who were exposed to the now-banned chemical pesticide, DDT, have 2-3 times higher chances of experiencing obesity and earlier periods.
A recent study found that granddaughters of women who were exposed to the now-banned chemical pesticide, DDT, have 2-3 times higher chances of experiencing obesity and earlier periods.
Pollen could play role increased COVID-19 infection rates, study suggests
The spring season correlates with increased pollen counts, and according to a new study, the common allergen could be making COVID-19 infection rates worse.
The spring season correlates with increased pollen counts, and according to a new study, the common allergen could be making COVID-19 infection rates worse.
Potential HIV vaccine utilizing same mRNA technology as COVID-19 vaccine shows promise in early human trial
A potential HIV vaccine that utilizes he same mRNA technology as the COVID-19 vaccine from Moderna is showing promising results.
A potential HIV vaccine that utilizes he same mRNA technology as the COVID-19 vaccine from Moderna is showing promising results.
J&J COVID-19 vaccine pause to remain in place while officials seek more evidence on rare clots
The pause on Johnson & Johnson’s COVID-19 vaccine will remain in place for now after U.S. health advisers said they need more evidence to make any decision about the rare blood clots reported.
The pause on Johnson & Johnson’s COVID-19 vaccine will remain in place for now after U.S. health advisers said they need more evidence to make any decision about the rare blood clots reported.
Delaware Valley Johnson & Johnson clinics closed a second day, while area county leaders devise strategies to keep vaccines going
Kelly Rule reports from Montgomery County as area county leaders revamp vaccination plans after Johnson & Johnson vaccine pause
Kelly Rule reports from Montgomery County as area county leaders revamp vaccination plans after Johnson & Johnson vaccine pause
2 new studies find UK B.1.1.7 coronavirus variant more transmissible, but not linked to COVID-19 severity
Two new studies analyzing the worrisome B.1.1.7 coronavirus variant that first emerged in the U.K. found that while the strain is more transmissible, it did not appear to cause more severe COVID-19 illness.
Two new studies analyzing the worrisome B.1.1.7 coronavirus variant that first emerged in the U.K. found that while the strain is more transmissible, it did not appear to cause more severe COVID-19 illness.
Researchers launch study on whether Apple Watch, iPhones can detect illnesses like COVID-19
A study to test out if Apple Watches and iPhones can detect certain illnesses, such as COVID-19, is accepting participants in the Seattle area.
A study to test out if Apple Watches and iPhones can detect certain illnesses, such as COVID-19, is accepting participants in the Seattle area.
Moderna CEO says company anticipates ‘a lot of variants’ of coronavirus in next year
Moderna CEO Stéphane Bancel said he anticipates the world will see many coronavirus variants over “the next year or so” and hopes to have a booster shot by the fall.
Moderna CEO Stéphane Bancel said he anticipates the world will see many coronavirus variants over “the next year or so” and hopes to have a booster shot by the fall.
Johnson & Johnson vaccine pause won’t impact NJ's push to open eligibility on Monday, Murphy says
New Jersey Governor Phil Murphy said Wednesday that the indefinite pause on the Johnson & Johnson one-shot COVID-19 vaccine will not have an impact on the state's plan to open eligibility to all adults on Monday.
New Jersey Governor Phil Murphy said Wednesday that the indefinite pause on the Johnson & Johnson one-shot COVID-19 vaccine will not have an impact on the state's plan to open eligibility to all adults on Monday.
7-day average of daily COVID-19 cases in US above 70,000 as states reopen, life resumes amid ongoing pandemic
As states continue to reopen, daily coronavirus cases in the United States are beginning to rise again, triggering worry among experts of a new COVID-19 surge.
As states continue to reopen, daily coronavirus cases in the United States are beginning to rise again, triggering worry among experts of a new COVID-19 surge.
Black Doctors Consortium addresses concerns over Johnson and Johnson vaccine
Dr. Ala Stanford, founder of the Black Doctors Consortium, joined Good Day Philadelphia to discuss the Johnson & Johnson vaccine.
Dr. Ala Stanford, founder of the Black Doctors Consortium, joined Good Day Philadelphia to discuss the Johnson & Johnson vaccine.
Abington Twp. red light cameras not a deterrent to speeding and reckless drivers, police say
In Montgomery County, Abington Township police say they’re seeing more reckless driving, during the pandemic and that is despite red light cameras at dangerous intersections.
In Montgomery County, Abington Township police say they’re seeing more reckless driving, during the pandemic and that is despite red light cameras at dangerous intersections.
6-year-old gets hero's welcome back to school after completing cancer treatment
Nathan Herber, 6, got a hero's welcome from his fellow classmates after completing his cancer treatments.
Nathan Herber, 6, got a hero's welcome from his fellow classmates after completing his cancer treatments.
NFL to restrict access of team employees who refuse COVID-19 vaccine without ‘bona fide’ reason
The NFL is requiring certain team employees to have a “bona fide” reason to forego the COVID-19 vaccine or get barred from restricted areas.
The NFL is requiring certain team employees to have a “bona fide” reason to forego the COVID-19 vaccine or get barred from restricted areas.
CDC investigating death possibly connected to Johnson & Johnson vaccine
The death of a woman who received the single-dose Johnson & Johnson vaccine is under investigation by federal health authorities as part of a broader probe into potential "adverse side effects" from the vaccine.
The death of a woman who received the single-dose Johnson & Johnson vaccine is under investigation by federal health authorities as part of a broader probe into potential "adverse side effects" from the vaccine.
Johnson & Johnson pauses COVID-19 vaccine trial after US recommends investigation of rare clotting reports
Johnson & Johnson said it will pause an ongoing trial of its COVID-19 vaccine after federal health officials recommended the action in the wake of six reported U.S. cases of a rare type of blood clotting following vaccination.
Johnson & Johnson said it will pause an ongoing trial of its COVID-19 vaccine after federal health officials recommended the action in the wake of six reported U.S. cases of a rare type of blood clotting following vaccination.
White House announces steps to curb Black maternal mortality rate
President Joe Biden announced steps Tuesday to address the high mortality rate of Black mothers in the United States through equal access to health care and combating systemic racism.
President Joe Biden announced steps Tuesday to address the high mortality rate of Black mothers in the United States through equal access to health care and combating systemic racism.
Mick Jagger, Dave Grohl collaborate on pandemic anthem about coming out of COVID-19 lockdown
Mick Jagger and Dave Grohl have teamed up for a hard-rock pandemic anthem called “Eazy Sleazy.”
Mick Jagger and Dave Grohl have teamed up for a hard-rock pandemic anthem called “Eazy Sleazy.”
Vaccination clinics across the Delaware Valley close amid Johnson & Johnson pause
Vaccinations sites across the Delaware Valley were forced to close after the Johnson & Johnson vaccine was paused.
Vaccinations sites across the Delaware Valley were forced to close after the Johnson & Johnson vaccine was paused.
Moderna says its COVID-19 vaccine greater than 90% effective against virus 6 months after second shot
Moderna said its latest Phase 3 clinical trial found that its vaccine remains greater than 90% effective against COVID-19, and greater than 95% effective against severe cases of COVID-19, six months after the second dose.
Moderna said its latest Phase 3 clinical trial found that its vaccine remains greater than 90% effective against COVID-19, and greater than 95% effective against severe cases of COVID-19, six months after the second dose.